Yuchun Lee, Director at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 7,000 shares at $272.76 ($1.9M) on 2022-04-07, disclosed to the SEC on 2022-04-08.
Open-market sale of $1.9M VRTX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $267.57 | 17 | $5K | 0.2% |
| 2 | $270.67 | 300 | $81K | 4.2% |
| 3 | $271.78 | 1,600 | $435K | 22.7% |
| 4 | $271.78 | 1,600 | $435K | 22.7% |
| 5 | $272.84 | 83 | $23K | 1.2% |
| 6 | $272.76 | 417 |
| $114K |
| 5.9% |
| 7 | $272.76 | 417 | $114K | 5.9% |
| 8 | $273.78 | 500 | $137K | 7.2% |
| 9 | $275.26 | 256 | $70K | 3.7% |
| 10 | $275.26 | 256 | $70K | 3.7% |
| 11 | $276.37 | 727 | $201K | 10.5% |
| 12 | $276.37 | 727 | $201K | 10.5% |
| 13 | $277.02 | 100 | $28K | 1.4% |
| Total | $273.28 avg | 7,000 | $1.9M | 100% |
| Filing → |
| VRTX | SELL | 2023-01-25 | $3.8M | — | Filing → |
| VRTX | SELL | 2023-01-19 | $1.5M | — | Filing → |
| VRTX | SELL | 2022-04-20 | $1.1M | — | Filing → |